Asston Pharmaceuticals Limited (BOM:544445)

India flag India · Delayed Price · Currency is INR
82.00
+4.00 (5.13%)
At close: Jun 17, 2026
Market Cap698.06M
Revenue (ttm)315.84M +26.1%
Net Income38.65M -10.6%
EPS4.92 -28.7%
Shares Out 8.51M
PE Ratio16.67
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,000
Open80.00
Previous Close78.00
Day's Range80.00 - 82.00
52-Week Range61.02 - 126.00
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateMay 29, 2026

About Asston Pharmaceuticals

Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hyd... [Read more]

Industry Pharmaceutical Preparations
Founded 2019
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544445
Full Company Profile

Financial Performance

In fiscal year 2026, Asston Pharmaceuticals's revenue was 315.84 million, an increase of 26.14% compared to the previous year's 250.39 million. Earnings were 38.65 million, a decrease of -10.63%.

Financial Statements